Alpharma, Pfizer Launch Generic Neurontin
115938
Alpharma Inc. ALO.N on Friday began  selling a cheaper generic version of Pfizer Inc.'s PFE.N $3  billion a year epilepsy drug Neurontin without waiting for a  court ruling on Pfizer's request to block the copycat medicine.
396597
ORLANDO, Florida  - Wal-Mart Stores Inc. on Thursday said it will expand a program offering generic drugs for $4 per prescription throughout Florida on Friday, and said it may bring the program to other U.S. states by the end of the year.
158083
The FDA is investigating Teva's generic version of Wellbutrin XL.
132487
For those that missed it last night, Biogen Idec (BIIB:Nasdaq - news - research) and Elan Pharmaceuticals (ELN:NYSE ADR - news - research) received FDA approval for their new multiple sclerosis drug, now called Tysabri (formerly known as Antegren.
591386
Tablets containing a combination of the blood pressure medication aliskiren and water pill hydrochlorothiazide have been approved by the Food and Drug Administration, the product's manufacturer, Novartis AG, said Monday.
445972
Pfizer Inc. has agreed to license a  set of potential drugs for the prevention of stroke and heart  attacks from Germany's Schering, the two companies said on  Wednesday.
214179
WASHINGTON -- Some influential members of Congress are renewing their pledge to help speed generic versions of the world's most expensive drugs to market.
418561
ORLANDO, Florida  - Wal-Mart Stores Inc. will expand a program offering generic drugs for $4 per prescription throughout Florida on Friday, and may bring the deal to other U.S. states before the end of the year, the retailer said on Thursday.
272534
BOSTON (CBS.MW) -- With the threat of generic competition looming over the pharmaceutical industry, Pfizer Inc. declared on Tuesday that the strength and breadth of its drugs under development will give the company an edge over its rivals.
496143
Target Corp.  said on Thursday that it will match Wal-Mart Stores Inc.'s  new, lower prices on generic drugs in all Florida Target pharmacies beginning on Friday.
614941
Danish biotech firm NeuroSearch has found enough patients to start Phase II trials with its NS2330 compound for the treatment of Alzheimer's and Parkinson's diseases, it said on Tuesday.
762852
Mylan Laboratories Inc.  said on Tuesday it won U.S. approval for its generic versions of Pfizer Inc.'s  blockbuster anti-depressant Zoloft.
157354
A generic version of Pfizer Inc.'s  PFE.N $3 billion epilepsy treatment Neurontin is set to hit  the U.S. market after Alpharma Inc. ALO.N said on Friday it  will sell the cheaper version.
402032
Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) , a maker of generic drugs, and King Pharmaceutical (KG.N: Quote, Profile, Research) on Wednesday reaffirmed their commitment
755344
A federal appeals court has cleared the way for Alpharma Inc. (ALO.N: Quote, Profile, Research) to launch a generic form of Pfizer Inc&#39;s (PFE.
254545
An Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Merckâs generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt.
750251
BOSTON (CBS.MW) -- Pharmaceutical conglomerates Schering-Plough and Bayer have entered into a broad joint-marketing deal Monday for several of the companies&#39; leading drugs.